4,4'-bis(methylsulfinyl)benzoin | 66660-05-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4,4'-bis(methylsulfinyl)benzoin
• 英文别名: p,p'-di(methylsulfinyl)benzoin；2-Hydroxy-1,2-bis(4-methylsulfinylphenyl)ethanone
• CAS: 66660-05-7
• 化学式: C₁₆H₁₆O₄S₂
• 分子量: 336.433
• InChiKey: DKLVEHGAHNCOGZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  110
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4,4'-bis(methylsulfinyl)benzoin 在 potassium hydride 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 反应 6.33h， 生成 5,6-Bis-(4-methanesulfinyl-phenyl)-2,3-dihydro-imidazo[2,1-b]thiazole 1-oxide
  参考文献：
  名称：

  5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents

  摘要：

  A series of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles were synthesized and evaluated in the rat adjuvant-induced arthritis and mouse oxazolone-induced contact sensitivity assays to determine the potential of these compounds for use as immunoregulatory antiinflammatory agents. This class of compounds was derived by combining salient structural features of the antiinflammatory agent flumizole and the immunoregulatory drug levamisole. Unlike the latter two, a number of compounds in the target series were found to possess the desired combination of activities. Exploration of structure-activity relationships in the adjuvant-induced arthritic rat assay revealed that optimal potency was exhibited by symmetrically substituted 5,6-diaryl compounds having one of the following alkyl heteroatom or halogen functions at the para position: methoxy, ethoxy, methylthio, N-ethyl-N-methylamino, fluoro, or chloro. Scrambling of these two substituent classes to yield the asymmetrically substituted 5,6-diaryl compounds resulted in potent activity only with the 5-alkyl heteroatom, 6-halo-substituted regioisomers. However in the oxazolone-induced contact sensitivity assay, no consistent relationship of variation in activity with structural change was apparent. The initial target compound 5,6-bis(4-methoxyphenyl)-2,3-dihydroimidazo[2,1-b]thiazole (1) was compared with its progenitors in additional models of inflammation and immunoregulation.

  DOI：

  10.1021/jm00147a008
• 作为产物：
  描述：

  2-hydroxy-1,2-bis(4-methylsulfanyl-phenyl)ethanone 在 间氯过氧苯甲酸 作用下， 以 氯仿 为溶剂， 生成 4,4'-bis(methylsulfinyl)benzoin
  参考文献：
  名称：

  5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles

  摘要：

  这些化合物是5,6-苯基-2,3-二氢咪唑[2,1-b]噻唑的衍生物，具有抗关节炎活性。其中一种优选的化合物是5,6-双(对甲氧基苯基)-2,3-二氢咪唑[2,1-b]噻唑。

  公开号：

  US04263311A1

文献信息

• 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
  申请人：SmithKline Corporation

  公开号：US04263311A1

  公开（公告）日：1981-04-21

  The compounds are 5,6-phenyl-2,3-dihydroimidazo[2,1-b]thiazoles which have antiarthritic activity. A preferred compound is 5,6-bis(p-anisyl)-2,3-dihydroimidazo[2,1-b]thiazole.

  这些化合物是5,6-苯基-2,3-二氢咪唑[2,1-b]噻唑的衍生物，具有抗关节炎活性。其中一种优选的化合物是5,6-双(对甲氧基苯基)-2,3-二氢咪唑[2,1-b]噻唑。
• BENDER, P. E.;HILL, D. T.;OFFEN, P. H.;RAZGAITIS, K.;LAVANCHY, P.;STRINGE+, J. MED. CHEM., 1985, 28, N 9, 1169-1177
  作者：BENDER, P. E.、HILL, D. T.、OFFEN, P. H.、RAZGAITIS, K.、LAVANCHY, P.、STRINGE+

  DOI：——

  日期：——
• US4263311A
  申请人：——

  公开号：US4263311A

  公开（公告）日：1981-04-21
• 5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents
  作者：Paul E. Bender、David Hill、Priscilla H. Offen、Kazys Razgaitis、Patricia Lavanchy、Orum D. Stringer、Blaine M. Sutton、Don E. Griswold、Michael DiMartino

  DOI：10.1021/jm00147a008

  日期：1985.9

  A series of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles were synthesized and evaluated in the rat adjuvant-induced arthritis and mouse oxazolone-induced contact sensitivity assays to determine the potential of these compounds for use as immunoregulatory antiinflammatory agents. This class of compounds was derived by combining salient structural features of the antiinflammatory agent flumizole and the immunoregulatory drug levamisole. Unlike the latter two, a number of compounds in the target series were found to possess the desired combination of activities. Exploration of structure-activity relationships in the adjuvant-induced arthritic rat assay revealed that optimal potency was exhibited by symmetrically substituted 5,6-diaryl compounds having one of the following alkyl heteroatom or halogen functions at the para position: methoxy, ethoxy, methylthio, N-ethyl-N-methylamino, fluoro, or chloro. Scrambling of these two substituent classes to yield the asymmetrically substituted 5,6-diaryl compounds resulted in potent activity only with the 5-alkyl heteroatom, 6-halo-substituted regioisomers. However in the oxazolone-induced contact sensitivity assay, no consistent relationship of variation in activity with structural change was apparent. The initial target compound 5,6-bis(4-methoxyphenyl)-2,3-dihydroimidazo[2,1-b]thiazole (1) was compared with its progenitors in additional models of inflammation and immunoregulation.